Experimental studies of the breakdown of Epontol: determination of propanidid in human serum.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000771:Anesthesia, Intravenous; D000773:Anesthesia, Obstetrical; D000777:Anesthetics / Q000008:administration & dosage / Q000097:blood* / Q000494:pharmacology; D002800:Cholinesterase Inhibitors; D002802:Cholinesterases / Q000097:blood; D002986:Clinical Trials as Topic; D004569:Electroencephalography; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D008431:Maternal-Fetal Exchange; D008875:Middle Aged; D011247:Pregnancy; D011485:Protein Binding; D012119:Respiration / Q000187:drug effects; D012709:Serum Albumin / Q000032:analysis; D013390:Succinylcholine / Q000494:pharmacology; D013501:Surface-Active Agents
D000777:Anesthetics; D002800:Cholinesterase Inhibitors; D012709:Serum Albumin; D013501:Surface-Active Agents; D002802:Cholinesterases; D013390:Succinylcholine